Skip to main content
Top
Published in: Advances in Therapy 6/2019

Open Access 01-06-2019 | Misoprostol | Review

Adjunctive Agents for Cervical Preparation in Second Trimester Surgical Abortion

Authors: Jessika A. Ralph, Lee P. Shulman

Published in: Advances in Therapy | Issue 6/2019

Login to get access

Abstract

Late second trimester dilation and evacuation is a challenging subset of surgical abortion. Among the reasons for this is the degree of cervical dilation required to safely extricate fetal parts. Cervical dilation is traditionally achieved by placing multiple sets of osmotic dilators over two or more days prior to the evacuation procedure; however, there is interest in shortening cervical preparation time. The use of adjuvant mifepristone and misoprostol in conjunction with osmotic dilators has been studied for this purpose, and their use demonstrates that adequate cervical dilation can be achieved in less time than with dilators alone. We present a review of the current evidence surrounding adjunctive agents for cervical preparation, and contend that for women presenting for surgical abortion care above 19 weeks gestation, the use of adjunctive mifepristone and/or misoprostol should be strongly considered along with osmotic dilator insertion when cervical preparation in less than 24 h is needed.
Literature
1.
go back to reference Kerns J, Vanjani R, Freedman L, Meckstroth K, Drey EA, Steinauer J. Women’s decision making regarding choice of second trimester termination method for pregnancy complications. Int J Gynaecol Obstet. 2012;116(3):244–8.CrossRef Kerns J, Vanjani R, Freedman L, Meckstroth K, Drey EA, Steinauer J. Women’s decision making regarding choice of second trimester termination method for pregnancy complications. Int J Gynaecol Obstet. 2012;116(3):244–8.CrossRef
2.
go back to reference Thorp JM Jr. Public health impact of legal termination of pregnancy in the US: 40 years later. Scientifica (Cairo). 2012;2012:980812. Thorp JM Jr. Public health impact of legal termination of pregnancy in the US: 40 years later. Scientifica (Cairo). 2012;2012:980812.
3.
go back to reference Peterson WF, Berry FN, Grace MR, Gulbranson CL. Second-trimester abortion by dilatation and evacuation: an analysis of 11,747 cases. Obstet Gynecol. 1983;62(2):185–90.PubMed Peterson WF, Berry FN, Grace MR, Gulbranson CL. Second-trimester abortion by dilatation and evacuation: an analysis of 11,747 cases. Obstet Gynecol. 1983;62(2):185–90.PubMed
4.
go back to reference Ngai SW, Chan YM, Tang OS, Ho PC. The use of misoprostol for pre-operative cervical dilatation prior to vacuum aspiration: a randomized trial. Hum Reprod. 1999;14(8):2139–42.CrossRef Ngai SW, Chan YM, Tang OS, Ho PC. The use of misoprostol for pre-operative cervical dilatation prior to vacuum aspiration: a randomized trial. Hum Reprod. 1999;14(8):2139–42.CrossRef
5.
go back to reference Nucatola D, Roth N, Saulsberry V, Gatter M. Serious adverse events associated with the use of misoprostol alone for cervical preparation prior to early second trimester surgical abortion (12–16 weeks). Contraception. 2008;78(3):245–8.CrossRef Nucatola D, Roth N, Saulsberry V, Gatter M. Serious adverse events associated with the use of misoprostol alone for cervical preparation prior to early second trimester surgical abortion (12–16 weeks). Contraception. 2008;78(3):245–8.CrossRef
6.
go back to reference MacIsaac L, Grossman D, Balistreri E, Darney P. A randomized controlled trial of laminaria, oral misoprostol, and vaginal misoprostol before abortion. Obstet Gynecol. 1999;93(5 Pt 1):766–70.PubMed MacIsaac L, Grossman D, Balistreri E, Darney P. A randomized controlled trial of laminaria, oral misoprostol, and vaginal misoprostol before abortion. Obstet Gynecol. 1999;93(5 Pt 1):766–70.PubMed
7.
go back to reference Allen RH, Goldberg AB. Cervical dilation before first-trimester surgical abortion (< 14 weeks’ gestation). Contraception. 2016;93:277–91.CrossRef Allen RH, Goldberg AB. Cervical dilation before first-trimester surgical abortion (< 14 weeks’ gestation). Contraception. 2016;93:277–91.CrossRef
8.
go back to reference Clark K, Ji H, Feltovich H, Janowski J, Carroll C, Chien EK. Mifepristone-induced cervical ripening: structural, biomechanical, and molecular events. Am J Obstet Gynecol. 2006;194(5):1391–8.CrossRef Clark K, Ji H, Feltovich H, Janowski J, Carroll C, Chien EK. Mifepristone-induced cervical ripening: structural, biomechanical, and molecular events. Am J Obstet Gynecol. 2006;194(5):1391–8.CrossRef
9.
go back to reference Gemzell-Danielsson K, Bygdeman M, Aronsson A. Studies on uterine contractility following mifepristone and various routes of misoprostol. Contraception. 2006;74(1):31–5.CrossRef Gemzell-Danielsson K, Bygdeman M, Aronsson A. Studies on uterine contractility following mifepristone and various routes of misoprostol. Contraception. 2006;74(1):31–5.CrossRef
10.
go back to reference Hayes JL, Fox MC. Cervical dilation in second-trimester abortion. Clin Obstet Gynecol. 2009;52(2):171–8.CrossRef Hayes JL, Fox MC. Cervical dilation in second-trimester abortion. Clin Obstet Gynecol. 2009;52(2):171–8.CrossRef
11.
go back to reference Shulman LP, Ling FW, Meyers CM, Shanklin DR, Simpson JL, Elias S. Dilation and evacuation for second-trimester genetic pregnancy termination. Obstet Gynecol. 1990;75(6):1037–40.PubMed Shulman LP, Ling FW, Meyers CM, Shanklin DR, Simpson JL, Elias S. Dilation and evacuation for second-trimester genetic pregnancy termination. Obstet Gynecol. 1990;75(6):1037–40.PubMed
12.
go back to reference Burnett MA, Corbett CA, Gertenstein RJ. A randomized trial of laminaria tents versus vaginal misoprostol for cervical ripening in first trimester surgical abortion. J Obstet Gynaecol Can. 2005;27(1):38–42.CrossRef Burnett MA, Corbett CA, Gertenstein RJ. A randomized trial of laminaria tents versus vaginal misoprostol for cervical ripening in first trimester surgical abortion. J Obstet Gynaecol Can. 2005;27(1):38–42.CrossRef
13.
go back to reference Edelman AB, Buckmaster JG, Goetsch MF, Nichols MD, Jensen JT. Cervical preparation using laminaria with adjunctive buccal misoprostol before second-trimester dilation and evacuation procedures: a randomized clinical trial. Am J Obstet Gynecol. 2006;194(2):425–30.CrossRef Edelman AB, Buckmaster JG, Goetsch MF, Nichols MD, Jensen JT. Cervical preparation using laminaria with adjunctive buccal misoprostol before second-trimester dilation and evacuation procedures: a randomized clinical trial. Am J Obstet Gynecol. 2006;194(2):425–30.CrossRef
14.
go back to reference Drey EA, Benson LS, Sokoloff A, Steinauer JE, Roy G, Jackson RA. Buccal misoprostol plus laminaria for cervical preparation before dilation and evacuation at 21–23 weeks of gestation: a randomized controlled trial. Contraception. 2014;89(4):307–13.CrossRef Drey EA, Benson LS, Sokoloff A, Steinauer JE, Roy G, Jackson RA. Buccal misoprostol plus laminaria for cervical preparation before dilation and evacuation at 21–23 weeks of gestation: a randomized controlled trial. Contraception. 2014;89(4):307–13.CrossRef
15.
go back to reference Patel A, Talmont E, Morfesis J, et al. Adequacy and safety of buccal misoprostol for cervical preparation prior to termination of second-trimester pregnancy. Contraception. 2006;73(4):420–30.CrossRef Patel A, Talmont E, Morfesis J, et al. Adequacy and safety of buccal misoprostol for cervical preparation prior to termination of second-trimester pregnancy. Contraception. 2006;73(4):420–30.CrossRef
16.
go back to reference Lyus R, Lohr PA, Taylor J, Morroni C. Outcomes with same-day cervical preparation with Dilapan-S osmotic dilators and vaginal misoprostol before dilatation and evacuation at 18 to 21+ 6 weeks’ gestation. Contraception. 2013;87(1):71–5.CrossRef Lyus R, Lohr PA, Taylor J, Morroni C. Outcomes with same-day cervical preparation with Dilapan-S osmotic dilators and vaginal misoprostol before dilatation and evacuation at 18 to 21+ 6 weeks’ gestation. Contraception. 2013;87(1):71–5.CrossRef
17.
go back to reference Boraas CM, Achilles SL, Cremer ML, Chappell CA, Lim SE, Chen BA. Synthetic osmotic dilators with adjunctive misoprostol for same-day dilation and evacuation: a randomized controlled trial. Contraception. 2016;94(5):467–72.CrossRef Boraas CM, Achilles SL, Cremer ML, Chappell CA, Lim SE, Chen BA. Synthetic osmotic dilators with adjunctive misoprostol for same-day dilation and evacuation: a randomized controlled trial. Contraception. 2016;94(5):467–72.CrossRef
18.
go back to reference Singh K, Fong YF, Prasad RN, Dong F. Randomized trial to determine optimal dose of vaginal misoprostol for preabortion cervical priming. Obstet Gynecol. 1998;92(5):795–8.PubMed Singh K, Fong YF, Prasad RN, Dong F. Randomized trial to determine optimal dose of vaginal misoprostol for preabortion cervical priming. Obstet Gynecol. 1998;92(5):795–8.PubMed
19.
go back to reference Singh K, Fong YF, Prasad RN, Dong F. Evacuation interval after vaginal misoprostol for preabortion cervical priming: a randomized trial. Obstet Gynecol. 1999;94(3):431–4.PubMed Singh K, Fong YF, Prasad RN, Dong F. Evacuation interval after vaginal misoprostol for preabortion cervical priming: a randomized trial. Obstet Gynecol. 1999;94(3):431–4.PubMed
20.
go back to reference Meckstroth KR, Whitaker AK, Bertisch S, Goldberg AB, Darney PD. Misoprostol administered by epithelial routes: drug absorption and uterine response. Obstet Gynecol. 2006;108(3 Pt 1):582–90.CrossRef Meckstroth KR, Whitaker AK, Bertisch S, Goldberg AB, Darney PD. Misoprostol administered by epithelial routes: drug absorption and uterine response. Obstet Gynecol. 2006;108(3 Pt 1):582–90.CrossRef
21.
go back to reference Borgatta L, Kapp N, Society of Family Planning. Clinical guidelines. Labor induction abortion in the second trimester. Contraception. 2011;84(1):4–18.CrossRef Borgatta L, Kapp N, Society of Family Planning. Clinical guidelines. Labor induction abortion in the second trimester. Contraception. 2011;84(1):4–18.CrossRef
22.
go back to reference Goldberg A, Fortin JA, Drey EA, et al. Cervical preparation before dilation and evacuation using adjunctive misoprostol or mifepristone compared with overnight osmotic dilators alone: a randomized controlled trial. Obstet Gynecol. 2015;126:599–609.CrossRef Goldberg A, Fortin JA, Drey EA, et al. Cervical preparation before dilation and evacuation using adjunctive misoprostol or mifepristone compared with overnight osmotic dilators alone: a randomized controlled trial. Obstet Gynecol. 2015;126:599–609.CrossRef
23.
go back to reference Shaw KA, Shaw JG, Hugin M, Velasquez G, Hopkins FW, Blumenthal PD. Adjunct mifepristone for cervical preparation prior to dilation and evacuation: a randomized trial. Contraception. 2015;91(4):313–9.CrossRef Shaw KA, Shaw JG, Hugin M, Velasquez G, Hopkins FW, Blumenthal PD. Adjunct mifepristone for cervical preparation prior to dilation and evacuation: a randomized trial. Contraception. 2015;91(4):313–9.CrossRef
24.
go back to reference Shaw KA, Lerma K, Shaw JG, et al. Preoperative effects of mifepristone for dilation and evacuation after 19 weeks of gestation: a randomised controlled trial. BJOG. 2017;124(13):1973–81.CrossRef Shaw KA, Lerma K, Shaw JG, et al. Preoperative effects of mifepristone for dilation and evacuation after 19 weeks of gestation: a randomised controlled trial. BJOG. 2017;124(13):1973–81.CrossRef
25.
go back to reference American College of Obstetricians and Gynecologists, Society of Family Planning. Medical management of first-trimester abortion. Contraception. 2014;89(3):148–61.CrossRef American College of Obstetricians and Gynecologists, Society of Family Planning. Medical management of first-trimester abortion. Contraception. 2014;89(3):148–61.CrossRef
26.
go back to reference Swahn ML, Bygdeman M. The effect of the antiprogestin RU 486 on uterine contractility and sensitivity to prostaglandin and oxytocin. Br J Obstet Gynaecol. 1988;95(2):126–34.CrossRef Swahn ML, Bygdeman M. The effect of the antiprogestin RU 486 on uterine contractility and sensitivity to prostaglandin and oxytocin. Br J Obstet Gynaecol. 1988;95(2):126–34.CrossRef
27.
go back to reference Creinin MD, Schreiber CA, Bednarek P, et al. Mifepristone and misoprostol administered simultaneously versus 24 hours apart for abortion: a randomized controlled trial. Obstet Gynecol. 2007;109(4):885–94.CrossRef Creinin MD, Schreiber CA, Bednarek P, et al. Mifepristone and misoprostol administered simultaneously versus 24 hours apart for abortion: a randomized controlled trial. Obstet Gynecol. 2007;109(4):885–94.CrossRef
28.
go back to reference Spitz IM, Bardin CW. Mifepristone (RU 486)—a modulator of progestin and glucocorticoid action. N Engl J Med. 1993;329(6):404–12.CrossRef Spitz IM, Bardin CW. Mifepristone (RU 486)—a modulator of progestin and glucocorticoid action. N Engl J Med. 1993;329(6):404–12.CrossRef
29.
go back to reference Bygdeman M, Swahn ML, Gemzell-Danielsson K, Svalander P. Mode of action of RU 486. Ann Med. 1993;25(1):61–4.CrossRef Bygdeman M, Swahn ML, Gemzell-Danielsson K, Svalander P. Mode of action of RU 486. Ann Med. 1993;25(1):61–4.CrossRef
Metadata
Title
Adjunctive Agents for Cervical Preparation in Second Trimester Surgical Abortion
Authors
Jessika A. Ralph
Lee P. Shulman
Publication date
01-06-2019
Publisher
Springer Healthcare
Published in
Advances in Therapy / Issue 6/2019
Print ISSN: 0741-238X
Electronic ISSN: 1865-8652
DOI
https://doi.org/10.1007/s12325-019-00953-2

Other articles of this Issue 6/2019

Advances in Therapy 6/2019 Go to the issue